What are the latest figures on the deep brain stimulation systems market’s size and projected CAGR?
The deep brain stimulation systems market size has grown rapidly in recent years. It will grow from $2.53 billion in 2024 to $2.79 billion in 2025 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to rising desire for less invasive operations among the general public, increasing demand for minimally invasive surgery in developed countries, rising demand for minimally invasive surgical procedures, high prevalence of diseases such as parkinson’s disease and epilepsy, increasing prevalence of neurological disorders.
The deep brain stimulation systems market size is expected to see rapid growth in the next few years. It will grow to $4.16 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to increasing growth in the geriatric population, rising prevalence of neurological disorders globally, growing aging population, increasing acceptance of neurostimulation therapies, rising healthcare infrastructure development. Major trends in the forecast period include technological advancements in deep brain stimulation devices, advancements in technology, focus on non-motor symptoms, miniaturization and advanced materials, wireless connectivity and remote monitoring, multimodal therapies.
Get Your Free Sample of The Global Deep Brain Stimulation Systems Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13834&type=smp
What are the key drivers behind the rapid expansion of the deep brain stimulation systems market?
The increasing prevalence of neurological disorders is expected to propel the growth of the deep brain stimulation systems market going forward. Neurological disorders refer to a group of heterogeneous diseases that affect the body’s autonomic, peripheral, and central nervous systems. Deep brain stimulation systems are used in neurosurgical procedures to send electrical stimulation to the desired area, aiming to alter or modulate neural functioning and achieve a reversible, adjustable, and therapeutic effect. For instance, in March 2023, according to the Parkinson’s Foundation, a US-based national organization, nearly 90,000 people were diagnosed with PD every year in the US, a 50% increase from the previously estimated rate of 60,000 diagnoses annually. Therefore, the increasing prevalence of neurological disorders is driving the growth of the deep brain stimulation systems market.
What is the segmentation for the deep brain stimulation systems market?
The deep brain stimulation systems market covered in this report is segmented –
1) By Product: Single Channel, Dual Channel
2) By Application: Parkinson’s Disease, Essential Tremor, Obsessive Compulsive Disorder, Epilepsy, Dystonia, Other Applications
3) By End-user: Hospitals, Ambulatory Surgical Centers, Neurological Clinics, Other End Users
Order your report now for swift delivery
Who are the most influential companies in the deep brain stimulation systems market?
Major companies operating in the deep brain stimulation systems market report are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Quest Diagnostics Inc., St. Jude Medical Inc., Stanford Health Care, Associated Regional and University Pathologists Inc., LivaNova PLC, OPKO Health Inc., Nordic Laboratories, Myriad Genetics Inc., Nevro Corporation, Genomic Health, Mayo Medical Laboratories, Foundation Medicine Inc., SceneRay Co., ACM Global Laboratories, Neuropace Inc., American Esoteric Laboratories, Nexstim Oy, Aleva Neurotherapeutics S.A., NeuroSigma Inc., Beijing PINS Medical Co. Ltd., BioMONTR Labs, Functional Neuromodulation Ltd., Miraca Holdings Inc., Nuvectra Corporation
What are the most influential trends expected to drive the deep brain stimulation systems market forward?
Major companies operating in the deep brain stimulation systems market are developing innovative technology, such as deep brain stimulation (DBS) systems, to treat patients with movement disorders. Deep Brain Stimulation (DBS) is a medical procedure that involves an implanted device that delivers an electrical current directly to areas of the brain. For instance, in January 2024, Abbott Laboratories, a US-based medical devices and health care company, launched the Liberta RC DBS system, the world’s smallest rechargeable deep brain stimulation (DBS) device with remote programming, to treat people living with movement disorders. The Liberta RC DBS system is the only rechargeable, first-of-its-kind connected care technology in the U.S. and enables patients to stay in touch with their physicians, guarantee optimal configuration and operation, and obtain updated treatment settings remotely when necessary without having to visit a physician’s office.
What are the major regional insights for the deep brain stimulation systems market, and which region holds the top position?
North America was the largest region in the deep brain stimulation systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deep brain stimulation systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Deep Brain Stimulation Systems Market Report 2025 Offer?
The deep brain stimulation systems market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
A deep brain stimulation (DBS) system is a medical device that uses implanted electrodes to deliver electrical pulses to specific areas of the brain. It is used to regulate abnormal brain activity and improve symptoms associated with a variety of neurological conditions.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13834
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
